Document:

EX-10.1

 Exhibit 10.1 

AMENDMENT TO EMPLOYMENT AGREEMENT 

This AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered on August 2, 2022 to be into effective as of
September 2, 2022 the (“Effective Date”), by and between Sonida Senior Living, Inc., a Delaware corporation (formerly Capital Senior Living Corporation) (the “Company”), and Brandon Ribar
(“Employee”). Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Employment Agreement (as defined below). 

WHEREAS, the Company and Employee are parties to that certain Employment Agreement dated September 10, 2019 (the “Employment
Agreement”); 
 WHEREAS, the parties hereto desire to amend the Employment Agreement as provided in this Amendment; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto,
intending to be legally bound, hereby agree to amend the Employment Agreement as follows: 
 1. Amendments. 

(a) Each reference to “Capital Senior Living Corporation” or “CSL” in the Employment Agreement is hereby replaced with
references to “Sonida Senior Living, Inc.” and “Sonida”, respectively. 
 (b) Sections 1, 2, and 3 of the Employment
Agreement are hereby amended and restated in their entirety to read as follows: 
 1. Appointment, Title and Duties; Service on the
Board and with Subsidiaries. 
  

	 	A)	 Commencing on the Effective Date, Sonida hereby employs Employee to serve in the positions as assigned to him
by its Board of Directors (the “Board”), which, as of the Effective Date, shall be as President and Chief Executive Officer. In such capacity, Employee shall report to the Board and shall have such powers, duties and responsibilities as
are customarily assigned said position and as may be otherwise assigned to him by the Board. 

  

	 	B)	 On or promptly following the Effective Date, Employee will be appointed as a member of the Board and shall
serve as a member of the Board without additional compensation. The Board will nominate Employee for reelection to the Board at the expiration of each term of office, and Employee agrees to serve as a member of the Board for each period for which he
is so elected. Employee shall, subject to his election as such from time to time and without additional compensation, serve in such additional offices in the Company’s subsidiaries and as member of any committee of the Board or of the board of
directors (or similar governing body) of any of the Company or its affiliates to which Employee may be appointed or elected from time to time. Upon termination of Employee’s employment for any reason, Employee shall be deemed to have resigned
from the Board and all other offices and board (or similar governing body) memberships, if any, then held with the Company or any of its affiliates, and, at the Company’s request, Employee will execute such documents as are necessary or
desirable to effectuate such resignations. 

 2. Term of Agreement. The term of this Agreement will begin on
the Effective Date and end on the first anniversary of the Effective Date; provided, however, that the term of this Agreement will automatically renew at the expiration of the then current term for additional
one-year periods unless, at least thirty (30) days prior to the expiration date of the then current term, either party gives written notice of nonrenewal to the other, in which event this Agreement and
Employee’s employment with the Company will terminate at the end of the term then in effect. Notwithstanding the foregoing, this Agreement and Employee’s employment with the Company will terminate upon the earlier of: (i) the date of
the voluntary resignation of Employee, (ii) the date of Employee’s death or determination of Employee’s disability (as defined in Paragraph 6 below), (iii) the date of notice by Sonida to Employee that this Agreement is being
terminated by Sonida whether “for cause” (as defined in Paragraph 6 below) or without cause, or (iv) upon the date a notice of intent to resign for “good reason” (as defined in Paragraph 6 below) is delivered to the Company
by Employee. 

 3. Acceptance of Position. Employee hereby accepts the positions assigned by
the Board, and agrees that during the term of this Agreement he will faithfully perform his duties and will devote substantially all of his business time to the business and affairs of Sonida and will not engage, for his own account or for the
account of any other person or entity, in any other business or enterprise except with the express written approval of the Board; provided, however, that Employee may (i) may serve on the board of directors of one (1) other public company,
(ii) engage in charitable, civic or political activities, and (iii) manage personal, passive investments, in each case so long as such activities do not materially interfere, individually or in the aggregate, with the performance of
Employee’s duties hereunder. Employee agrees to perform his duties faithfully, diligently and to the best of his ability, to use his best efforts to advance the best interests of the Company at all times, and to abide by all moral, ethical and
lawful policies, guidelines, procedures, instructions and orders given to him by the Company from time to time. 
 (c) Section 4.A of the
Employment Agreement is hereby amended and restated in its entirety to read as follows: 
  

	 	A)	 i.) Sonida shall pay or cause to be paid to Employee a base salary at an annual rate of not less than Four
Hundred Fifty Thousand Dollars ($450,000.00) per annum, paid in approximately equal installments no less frequently than semi-monthly. 

ii.) For the 2022 fiscal year and each fiscal year thereafter during the term of this Agreement, Employee will be eligible to receive an annual
bonus in the target amount of 75% of Employee’s base salary. 
 (d) The last sentence of Section 10 of the Employment Agreement is
hereby amended and restated in its entirety to read as follows: 
 The Employee will promptly disclose such Work Product to the Board and
perform all actions reasonably requested by the Board (whether during or after the term of this Agreement) to establish and to confirm such ownership (including, without limitation, assignments, consents, powers of attorney and other instruments).

 (e) The last sentence of Section 14 of the Employment Agreement is hereby amended to replace “Paragraphs 7, 8, 9, and 10”
with “the last sentence of Paragraph 1.B. and Paragraphs 7 through 19”. 
 (f) The third paragraph of Section 19 of the
Employment Agreement is hereby amended to replace “Employment Period” with “term of this Agreement”. 
 2. Effect of
Amendment. This Amendment shall only serve to amend and modify the Employment Agreement to the extent specifically provided herein. All terms, conditions, provisions and references of and to the Employment Agreement, which are not specifically
modified, amended and/or waived herein, shall remain in full force and effect and shall not be altered by any provisions herein contained. All prior agreements, promises, negotiations and representations, either oral or written, relating to the
subject matter of this Amendment or the Employment Agreement (as amended hereby) that are not expressly set forth in this Amendment or the Employment Agreement (as amended hereby) are of no force or effect. 

3. Miscellaneous. This Amendment may be executed in one or more counterparts, each of which when executed and delivered shall be deemed
to be an original and all counterparts taken together shall constitute one and the same instrument. This Amendment and the Employment Agreement (as amended hereby) constitute the entire understanding of the parties hereto with respect to the subject
matter hereof, and any and all prior agreements and understandings between the parties regarding the subject matter hereof, whether written or oral, except for the Employment Agreement (as amended hereby), are superseded by this Amendment. Any
provision of this Amendment that is invalid or unenforceable in any jurisdiction shall be ineffective to the extent of such invalidity or unenforceability without invalidating or rendering unenforceable the remaining provisions hereof, and any
invalidity or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 

[Remainder of page intentionally left blank.] 

 IN WITNESS WHEREOF, the undersigned have duly executed this Amendment as of the date first
written above. 
  

			
	SONIDA SENIOR LIVING, INC.
		
	By:	 	 /s/ David W. Johnson

		 	Name: David W. Johnson
		 	Title: Chairman, Board of Directors
	
	 /s/ Brandon Ribar

	Brandon Ribar

 [Signature Page to Amendment to Employment Agreement]EX-10.1

  Exhibit 10.1

  FORMA THERAPEUTICS HOLDINGS, INC.

   

  AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

   

  The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of Forma Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), is to provide a total compensation package that enables the Company to attract and retain, on a long-term basis, high- caliber directors who are not employees or officers of the Company or its subsidiaries (“Outside Directors”). This Policy will become effective as of the effective time of the registration statement for the Company’s initial public offering of equity securities (the “Effective Date”). In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:

   

  I.Cash Retainers

   

  (a)Annual Retainer for Board Membership: $40,000 for general availability and participation in meetings and conference calls of our Board of Directors. No additional compensation for attending individual Board meetings.

   

  (b)Additional Annual Retainers for Committee Membership:

   

  		
	Audit Committee Chairperson:
	$15,000

	 
	 

	Audit Committee member:
	$7,500

	 
	 

	Compensation Committee Chairperson:
	$10,000

	 
	 

	Compensation Committee member:
	   $5,000

	 
	 

	Nominating and Corporate Governance Committee Chairperson:
	 $8,000

	 
	 

	Nominating and Corporate Governance Committee member:
	$4,000

	 
	 

	Research & Development Committee Chairperson:
	 $10,000

	 
	 

	Research & Development Committee member:
	$5,000

   

  (c)Additional Annual Retainer for Non-Executive Chairman of the Board: $30,000.

   

  II.Equity Retainers

   

  All grants of equity retainer awards to Outside Directors pursuant to this Policy will be automatic and nondiscretionary and will be made in accordance with the following provisions:

   

  (d)Revisions. Subject to approval from the Board of Directors, the Compensation Committee may change and otherwise revise the terms of awards to be granted under this Policy, including, without limitation, the number of shares subject thereto, for awards of the same or different type granted on or after the date the Compensation Committee determines to make any such change or revision.

   

  (e)Sale Event Acceleration. In the event of a Sale Event (as defined in the Company’s 

  

  2020 Stock Option and Incentive Plan (the “2020 Plan”)), the equity retainer awards granted to Outside Directors pursuant to this Policy shall become 100% vested and exercisable.

   

  (f)Initial Grant.  Each new Outside Director will receive  an initial, one-time (i) stock option grant to purchase 13,500 shares of the Company’s common stock (the “Option Grant”) and (ii) restricted stock unit grant for 9,000 shares of the Company’s common stock (the “RSU Grant”)  (the Option Grant and RSU Grant, collectively, the “Initial Grant”). 33.3% of the shares subject to the Initial Grant shall vest  on the first anniversary of the applicable vesting commencement date and the remaining 66.7% of the shares subject to the Option Grant shall vest and become exercisable in 24 equal monthly installments thereafter, while 66.7% of the shares subject to the RSU Grant shall vest in 2 equal annual installments thereafter; provided, however, that all vesting ceases if the director ceases to provide services to the Company, unless the Board of Directors determines that the circumstances warrant continuation of vesting.

   

  (g)Annual Grant. On the date of the Company’s annual meeting of stockholders, each Outside Director who will continue as a member of the Board of Directors following such annual meeting of stockholders will receive on the date of such annual meeting (i) a stock option grant to purchase 6,750 shares of the Company’s common stock and (ii) a restricted stock unit grant for 4,500 shares of the Company’s common stock (the “Annual Grant”). All of the shares  subject to the Annual Grant shall vest and become exercisable upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next Annual Meeting of Stockholders; provided, however, that all vesting ceases if the director ceases to provide services to the Company, unless the Board of Directors determines that the circumstances warrant continuation of vesting.

   

  III.Expenses

   

  The Company will reimburse all reasonable out-of-pocket expenses incurred by Outside Directors in attending meetings of the Board of Directors or any Committee thereof.

   

  IV.Maximum Annual Compensation

   

  The aggregate amount of compensation, including both equity compensation and cash compensation, paid to any Outside Director in a calendar year period shall not exceed $750,000; provided, however that such amount shall be $1,000,000 for the calendar year in which the applicable Outside Director is initially elected or appointed to the Board (or such other limit as may be set forth in Section 3(b) of the 2020 Plan or any similar provision of a successor plan). For this purpose, the “amount” of equity compensation paid in a calendar year shall be determined based on the grant date fair value thereof, as determined in accordance with ASC 718 or its successor provision, but excluding the impact of estimated forfeitures related to service-based vesting conditions.

   

   

  Date Approved: May 14, 2020, as amended on July 28, 2020, June 17, 2021 and June 8, 2022.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]